相关实验视频

Updated: Jul 17, 2025

Using a Real-Time Locating System to Measure Walking Activity Associated with Wandering Behaviors Among Institutionalized Older Adults

Using a Real-Time Locating System to Measure Walking Activity Associated with Wandering Behaviors Among Institutionalized Older Adults

Published on: February 8, 2019

非面对面的综合老年护理应用程序"智能银护理"对社区老年人的有效性:随机对照试验

Dahye Hong¹, Seon Heui Lee²

¹Department of Health Policy and Management, Graduate School of Public Health, Yonsei University, Seoul, Republic of Korea.

|September 1, 2023

概括

智能银护理,一个数字健康应用程序,改善了老年人的跌倒风险得分. 虽然它没有显著影响抑郁症或生活质量,但它显示出积极的趋势,并且易于使用.

科学领域:

老年学是一门学科.
数字健康数字健康
老年人护理医疗老年人护理

背景情况:

老年人的生活质量是一个日益关注的问题.
传统的面对面服务受到COVID-19流行病等因素的限制.
越来越需要在线老年护理解决方案.

研究的目的:

为了评估"智能银护理"应用程序的有效性,一个非面对面的老年护理服务.
评估数字干预对社区老年人的福祉的影响.

主要方法:

一项随机对照试验与60名老年参与者进行.
参与者使用平板电脑和智能手表进行身体,情绪和认知计划.
参与者和研究人员之间的实时通信和远程监督得到了促进.

主要成果:

在跌倒风险指标中观察到显著的改善:活动特异平衡信心 (ABC) 尺度 (p=0.028) 和定时升级和移动 (TUG) 测试 (p=0.001).
对于抑郁症 (SGDS-K) 或生活质量 (EQ-5D-5L) 没有发现统计学上显著的按时间分组相互作用.
干预组中的趋势表明抑郁症和生活质量有所改善.

结论:

智能银护理有效地改善了社区居住的老年人的TUG和ABC分数.
质量反证实了该应用程序在老年人中的可用性.
智能银护理提出了一个可行的数字干预措施,以提高老年人的身体生活质量.

关键词:

申请申请表申请表申请表社区生活的老年人.照顾老年人的关怀没有面对面的干预.人们的生活质量.

更多相关视频

A Training Program Using an Agility Ladder for Community-Dwelling Older Adults

A Training Program Using an Agility Ladder for Community-Dwelling Older Adults

Published on: March 7, 2020

Assessment of Dependence in Activities of Daily Living Among Older Patients in an Acute Care Unit

Assessment of Dependence in Activities of Daily Living Among Older Patients in an Acute Care Unit

Published on: September 30, 2020

相关概念视频

Documentation in Long-Term and Home Healthcare Setting

Documentation in Long-Term and Home Healthcare Setting

Documentation in long-term care facilities and home healthcare settings is crucial for ensuring continuous, coordinated, and comprehensive care for patients. Each setting has its specific documentation processes and tools:
Long-Term Care Facilities

Alzheimer's Disease: Treatment

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...